IL1B and chronic kidney disease: Lucisano et al. demonstrated that chronic kidney disease patients displayed lower vitamin D levels and higher expression of inflammatory markers, and vitamin D supplementation induced a significant reduction of IL-6, IL-17, IFN-Υ, TNF-α, and IL-1β in these patients [32].